Trend Direction
MEDICINAL AND BOTANICAL MANUFACTURING increased from FY2024 to FY2025, moving from $91,673 to $354,529 in the ingested records.
- Latest: $354,529
- Previous: $91,673
NAICS 325411 includes $494,515 in federal contract obligations across 68 ingested award records.
MEDICINAL AND BOTANICAL MANUFACTURING has $494,515 in ingested federal contract obligations across 68 award records in this naics profile.
Source: USAspending.gov. Last updated from ingested federal spending data: May 7, 2026.
MEDICINAL AND BOTANICAL MANUFACTURING has $494,515 across 68 ingested award records, with the analysis below generated only from visible tables on this page.
MEDICINAL AND BOTANICAL MANUFACTURING increased from FY2024 to FY2025, moving from $91,673 to $354,529 in the ingested records.
DMS PHARMACEUTICAL GROUP INC accounts for 84.5% of MEDICINAL AND BOTANICAL MANUFACTURING's visible obligations in this slice, which is the first concentration signal to review before treating the market as broad or fragmented.
Department of Defense is the largest visible secondary category at $447,592. Use this alongside the relationship table to separate one-off award activity from repeat market exposure.
The latest displayed award is SPE2D325F082G from FY2025 with $81,735 in obligations. Recent rows help identify whether the profile is still active in current procurement data.
| FY202556 awards | $354,529 |
| FY20245 awards | $91,673 |
| FY20236 awards | $1,390 |
| FY20211 awards | $46,923 |
| DMS PHARMACEUTICAL GROUP INC42 awards | $417,668 |
| UNITED OXYGEN COMPANY, INC.1 awards | $46,923 |
| AMERISOURCEBERGEN DRUG CORP12 awards | $20,701 |
| EAGLE PHARMACEUTICALS, INC.1 awards | $7,057 |
| MR UNLIMITED, LLC6 awards | $1,390 |
| THE HARVARD DRUG GROUP, L.L.C.1 awards | $639 |
| CONCORDANCE HEALTHCARE SOLUTIONS LLC4 awards | $88 |
| MEDLINE INDUSTRIES, LP1 awards | $49 |
| Department of Defense67 awards | $447,592 |
| Department of Health and Human Services1 awards | $46,923 |
| Award | Recipient | Fiscal year | Obligations | Date |
|---|---|---|---|---|
| SPE2D325F082G | DMS PHARMACEUTICAL GROUP INC | 2025 | $81,735 | Not available |
| HHSN263201800089A | UNITED OXYGEN COMPANY, INC. | 2021 | $46,923 | Not available |
| SPE2D324F209X | DMS PHARMACEUTICAL GROUP INC | 2024 | $36,638 | Not available |
| SPE2D324F184L | DMS PHARMACEUTICAL GROUP INC | 2024 | $32,501 | Not available |
| SPE2D325F144S | DMS PHARMACEUTICAL GROUP INC | 2025 | $32,110 | Not available |
| SPE2D325F7908 | DMS PHARMACEUTICAL GROUP INC | 2025 | $26,856 | Not available |
| SPE2D325F8769 | DMS PHARMACEUTICAL GROUP INC | 2025 | $26,856 | Not available |
| SPE2D325F0008 | DMS PHARMACEUTICAL GROUP INC | 2025 | $26,592 | Not available |
| SPE2D225F0001 | DMS PHARMACEUTICAL GROUP INC | 2025 | $25,224 | Not available |
| SPE2D325F289Q | DMS PHARMACEUTICAL GROUP INC | 2025 | $23,706 | Not available |
MEDICINAL AND BOTANICAL MANUFACTURING has $494,515 in ingested federal contract obligations across 68 award records in this naics profile.
MEDICINAL AND BOTANICAL MANUFACTURING has $494,515 in ingested contract obligations across 68 award records.
DMS PHARMACEUTICAL GROUP INC is the largest listed relationship in this profile at $417,668.
Department of Defense is the largest listed secondary category at $447,592.
Source: USAspending.gov. Last updated from ingested federal spending data: May 7, 2026.